Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

YM BioSciences Inc YMI



NYSEAM:YMI - Post by User

YM BioSciences Inc > Is that all it's worth????
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by daydream1on Dec 15, 2010 8:40am
595 Views
Post# 17848539

RE: Is that all it's worth????

RE: Is that all it's worth????Due to there additional trial I was anticipating YM to be in need of more cash, but as you mentioned I too am disappointed at the $1.60 offer.  For one I was hoping that YM would take in a partnership with a big pharm to help them carry all the coast of the mounting number trials they have.  And second I think that the offer should had been price at about $2.00.  Too bad.  YM has too much on their plate to carry all of it without support of a partner...

Goodluck
D.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities